Elite Pharmaceuticals (OTCMKTS:ELTP) Receives FDA Approval for Generic Vyvanse®
On November 18, 2024, Elite Pharmaceuticals, Inc. (Elite) announced in a press release that it had secured approval from the US Food and Drug Administration (FDA) for a generic version of Vyvanse® ...